If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
 Journal of Lower Genital Tract DiseaseVolume 4 Issue 3, Pages 128 - 134 Published Online: 25 Dec 2001 2002 The American Society for Colposcopy and Cervical Pathology
Abstract | References | Full Text: HTML, PDF (Size: 405K) | Related Articles | Citation Tracking  Treatment of External Genital Warts This article was presented as a paper at the 10th World Congress of Cervical Pathology and Colposcopy, November 7–11, 1999, Buenos Aires, Argentina. Copyright 2000 ASCCP KEYWORDS external genital warts • human papillomavirus • imiquimod • recurrence • treatment ABSTRACTAbstract: To date the most widely used therapies for the treatment of external genital warts (EGWs) have been ablative techniques, some of which have serious side effects and result in high recurrence. This is frustrating for both patients and physicians. More recently, patient-applied therapies have become available, which offer several advantages over provider-administered therapies, and are generally preferred by the patients. The newest of these is imiquimod 5% cream. Its mode of action, stimulating the immune system to deal with the human papillomavirus (HPV), provides an effective treatment. Results obtained in clinical trials with imiquimod are described here, in the context of a recommended treatment protocol for EGWs. In addition, the potential for imiquimod to treat other HPV lesions is discussed. |  |
